Table 1 The clinical features of patients and healthy controls
Grouping | Serial number | Age (years) | Gender | EOS% | T-IgE (KU/l) | sIgE |
|---|---|---|---|---|---|---|
Normal control | NC-1 | 2 | female | 0.01 | 17.68 | Phadiatop:0.02 PUA/L |
NC-2 | 7 | male | 0.3 | 35.30 | Phadiatop:0.01 PUA/L | |
NC-3 | 5 | male | 0.1 | 127.00 | Phadiatop:0.05 PUA/L | |
Dust mite sensitized group | T-1 | 3 | male | 8.3 | 222.83 | hx2: 13.90 KUA/L |
T-2 | 4 | female | 5.4 | 243.09 | hx2:33.53 KUA/L | |
T-3 | 8 | male | 13.2 | 143.85 | hx2:27.29 KUA/L |